MA Ramirez, NL Borja: Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy. In: Pharmacotherapy. 28. Jahrgang, Nr.5, Mai 2008, S.646–655, doi:10.1592/phco.28.5.646, PMID 18447661.
O El-Kabbani, A Podjarny: Selectivity determinants of the aldose and aldehyde reductase inhibitor-binding sites. In: Cell. Mol. Life Sci. 64. Jahrgang, Nr.15, August 2007, S.1970–1978, doi:10.1007/s00018-007-6514-3, PMID 17497245.
A. Corso, M. Cappiello, U. Mura: From a Dull Enzyme to Something Else: Facts and Perspectives Regarding Aldose Reductase. In: Current Medicinal Chemistry. Band15, Nr.15, 2008, S.1452–1461, doi:10.2174/092986708784638870, PMID 18537622.
google.de
books.google.de
Jeremy M. Berg, John L. Tymoczko, Lubert Stryer, Gregory J. Gatto jr.: Stryer Biochemie. Springer-Verlag, 2014, ISBN 978-3-8274-2988-9, S.476 (eingeschränkte Vorschau in der Google-Buchsuche).
nih.gov
ncbi.nlm.nih.gov
MA Ramirez, NL Borja: Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy. In: Pharmacotherapy. 28. Jahrgang, Nr.5, Mai 2008, S.646–655, doi:10.1592/phco.28.5.646, PMID 18447661.
O El-Kabbani, A Podjarny: Selectivity determinants of the aldose and aldehyde reductase inhibitor-binding sites. In: Cell. Mol. Life Sci. 64. Jahrgang, Nr.15, August 2007, S.1970–1978, doi:10.1007/s00018-007-6514-3, PMID 17497245.
A. Corso, M. Cappiello, U. Mura: From a Dull Enzyme to Something Else: Facts and Perspectives Regarding Aldose Reductase. In: Current Medicinal Chemistry. Band15, Nr.15, 2008, S.1452–1461, doi:10.2174/092986708784638870, PMID 18537622.
